Telo Genomics Correlations
| TDSGF Stock | USD 0.07 0.01 13.58% |
The current 90-days correlation between Telo Genomics Corp and EXACT Sciences is -0.07 (i.e., Good diversification). The correlation of Telo Genomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Telo |
The ability to find closely correlated positions to Telo Genomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telo Genomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telo Genomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telo Genomics Corp to buy it.
Moving together with Telo OTC Stock
| 0.63 | SHG | Shinhan Financial | PairCorr |
| 0.78 | EC | Ecopetrol SA ADR | PairCorr |
| 0.74 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.68 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Telo OTC Stock
| 0.8 | WMT | Walmart Aggressive Push | PairCorr |
| 0.75 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.75 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.75 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.73 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.65 | VFS | VinFast Auto Earnings Call This Week | PairCorr |
| 0.64 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.6 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.58 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.55 | HPQ | HP Inc | PairCorr |
| 0.54 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.43 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.43 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.37 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.34 | KB | KB Financial Group | PairCorr |
Related Correlations Analysis
| -0.55 | 0.32 | 0.09 | 0.33 | EXAS | ||
| -0.55 | -0.4 | 0.14 | -0.1 | NTRA | ||
| 0.32 | -0.4 | -0.53 | 0.33 | CDNA | ||
| 0.09 | 0.14 | -0.53 | 0.12 | ILMN | ||
| 0.33 | -0.1 | 0.33 | 0.12 | TWST | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Telo OTC Stock performing well and Telo Genomics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Telo Genomics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EXAS | 2.26 | 0.10 | 0.00 | 0.06 | 0.00 | 6.01 | 33.31 | |||
| NTRA | 2.31 | 0.39 | 0.15 | 0.49 | 2.25 | 4.30 | 25.26 | |||
| CDNA | 2.52 | (0.50) | 0.00 | (0.40) | 0.00 | 4.05 | 24.22 | |||
| ILMN | 1.76 | 0.05 | 0.01 | 0.19 | 2.00 | 3.90 | 12.84 | |||
| TWST | 3.01 | (0.24) | (0.02) | 0.02 | 3.83 | 6.77 | 17.59 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Telo Genomics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Telo Genomics Corporate Executives
Elected by the shareholders, the Telo Genomics' board of directors comprises two types of representatives: Telo Genomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telo. The board's role is to monitor Telo Genomics' management team and ensure that shareholders' interests are well served. Telo Genomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telo Genomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sabine Mai | Member Founder | Profile |